Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
DISCHARGE SUMMARY FORMAT REMINDERS DISCHARGE SUMMARY FORMAT If the discharge summary is completed more than 24 hours prior to discharge, an addendum is required. Admitting Diagnosis Discharge summaries should be concise, preferably no longer than two to three pages. Procedures Do not use any dangerous abbreviations. Common examples include: Use “daily” instead of qd Use “every other day” instead of qod Use “units” instead of iu or u Principal Discharge Diagnosis Secondary Diagnoses Attending MD and phone # Primary Care MD Consultations Discharge Medications Anticoagulation Allergies/Adverse Drug Reactions Do not forget to reconcile admission and discharge medications. Discharge Treatments The principal discharge diagnosis is the condition established after study to be chiefly responsible for admission to the hospital. Follow-up & Outstanding Issues/Tests Diet/Nutrition/Activity Presentation on Admission (including admission medication list) Hospital Course Code Status/Advanced Directives Communication with PCP Disposition To Dictate: Insert dictation system instructions here. I DISCHARGE SUMMARY Admitting Diagnosis Principal Discharge Diagnosis Secondary Diagnoses- Present on admission Secondary Diagnoses- Acquired after admission II Presentation on Admission (brief, focused, pertinent): Chief Complaint History of present illness PMH/PSH Procedures Performed Medication on Admission Procedure, Date, Findings Name, dose, route, frequency (obtain data from medication reconciliation sheet) Attending Physician/Contact MD at Hospital Name and phone number Admission physical exam (brief, focused, SPECIAL POPULATIONS CHF Patients Include: Discharge weight Target weight and blood pressure Most recent BUN, creatinine, Na, K, EF with date If not on beta blockers, why not? If not on ACE-I or ARB, why not? Document discharge instructions given (activities, diet, meds, follow-up appointment, daily weight and signs/symptoms of worsening CHF) pertinent) Diabetes Patients – If not on ACE-I or PCP Pertinent Admission Labs and Diagnostic Studies ARB, explain why. Document Pneumovax and influenza vaccine (October-March). Administer if needed. Last known HgbA1C and date. Consultations Hospital Course by Problem or Diagnosis Including: Name and phone number if other than attending Service, doctor’s name, phone number Discharge Medications Name, dose, route and frequency. Indicate changes from admission meds Anticoagulation Agent(s) used, indication, target INR, anticipated duration and follow up plan (responsible MD or clinic and lab follow up). Last three INRs and warfarin doses if warfarin is new drug or dose changed Allergies/Adverse Drug Reactions Medication and type of reaction Discharge Treatments PT, OT, Nursing, Wound Care/Suture Removal Diet/Nutrition/Activity Consultations- service/names Treatment rendered and response to treatment Medication changes Pertinent tests/labs with results Procedure with results Complications Condition at Discharge Follow-up including any problem that needs close attention MI Patients – If patient not on ASA, beta blocker, statin or ACE-I/ARB at discharge explain why Orthopedic Patients DVT Prevention, Wound Care, Activity Patients > 65 - Document Pneumovax and influenza vaccine (October-March). Administer if needed Pediatric Patients Code Status/Advanced Directives Hearing test, Hep B, car seat challenge, Synagis given or indicated in winter, state screen, d/c weight, length and head circumference Communication with PCP Surgical Patients Document date and method of communication of patient handoff with PCP Disposition: Home with VNA, rehab, SNF, hospital transfer or expired Wound care, Activity level, Follow-up plans with Surgeon Smokers Document whether tobacco cessation counseling was provided Follow-up post discharge MD follow-up (include date or approximate time frame), pending test results and specific problems that require further testing/monitoring Created by: Adrienne Bennett, MD, PhD